StockTipsArenaBeta

BUY Eris Lifesciences Limited — Prabhudas Lilladher

BUYEris Lifesciences Limited
Eris Lifesciences share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1 year)27 Oct 2026via Moneycontrol Broker Research

Entry₹1,198.4Inferred
Target₹1,500
Total upside +25.17%
Stop lossNot given
CMP₹1,307.21d ago
Active+9.08%+14.75%upside left 12 mo left
Follow Prabhudas Lilladher for new calls(71% target hit, 430 closed calls)Get alertsWatch ERIS for new buy/sell callsGet alertsSee 5 other Long-term calls on ERISSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:31 am IST
5 supporting7 neutral2 opposing
Supports the BUY call (5)

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·28 Aug · 3mo ago

Neutral / worth noting (7)

Eris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·26 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (2)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·13 Nov · yesterday

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Eris Lifesciences

All analyst calls on Eris Lifesciences

More from Prabhudas Lilladher

Every call and its outcome